Companhia de Saneamento do Parana Sanepar (SAPR3)

Currency in BRL
7.69
+0.03(+0.39%)
Closed·

SAPR3 Financial Summary

Key Ratios

P/E Ratio4.89
Price/Book0.87
Debt / Equity54.91%
Return on Equity21.43%
Dividend Yield5.34%
EBITDA2.61B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of BRL (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.57%
Dividend Yield
5.34%
Industry Median 2.87%
Annualised payout
0.41
Paid unevenly
5-Years Growth
+4.47%
Growth Streak

Earnings

Latest Release
May 08, 2025
EPS / Forecast
0.80 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What were SANEPAR ON N2's earnings for the latest quarter?

The SANEPAR ON N2 EPS (TTM) is 1.57. SANEPAR ON N2 reported sales of 1,805.23, net income of 1,207.99, and EPS of 0.80 for the latest quarter.

What was SANEPAR ON N2's net income for the latest quarter?

SANEPAR ON N2's net income for the latest quarter was 1,207.99.

How did SANEPAR ON N2's performance compare year-over-year in the latest quarter?

The company's revenue moved from 1,776.21 in the previous quarter to 1,805.23 in the latest quarter, and net income moved from 412.87 to 1,207.99 compared to the previous quarter.

What is SANEPAR ON N2's net profit margin on a TTM basis?

SANEPAR ON N2's trailing twelve months (TTM) net profit margin is 22.57%.

How does SANEPAR ON N2's debt to equity ratio compare to industry standards?

SANEPAR ON N2's total debt-to-equity ratio is 54.91%.

What is SANEPAR ON N2's return on investment on a TTM basis?

SANEPAR ON N2's trailing twelve months (TTM) return on investment (ROI) is 21.43%.

Did SANEPAR ON N2 gain or lose cash last quarter?

In the latest quarter, SANEPAR ON N2's net change in cash was 47.87 million.

What were SANEPAR ON N2's total assets and liabilities in the latest quarter?

As of the latest quarter, SANEPAR ON N2 reported total assets of 24,877.80 million and total liabilities of 2,301.65 million.

How has SANEPAR ON N2's total revenue grown this year?

SANEPAR ON N2's total revenue was 1,776.21 in the previous quarter and 1,805.23 in the latest quarter.

What is SANEPAR ON N2's gross margin on a TTM basis?

SANEPAR ON N2's trailing twelve months (TTM) gross margin is 56.21%.

What was SANEPAR ON N2's revenue per share for the latest quarter?

SANEPAR ON N2's revenue per share for the latest quarter was 28.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.